Skip to main content
S&P 5007,765.36-0.47%DOW51,231.64+0.10%NASDAQ27,193.34-1.25%BTC$82,437.00+0.02%ETH$2,488.81-1.91%GOLD$4,203.90+1.13%OIL$90.51-1.07%
Smart Investors Daily
SID Premium
RO

NASDAQ · ROIVW

Roivant Sciences Ltd.

Healthcare · Biotechnology

$2.75

Up+$0.12 (+4.56%)

Updated Oct 9, 2026, 11:15 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
7.83B
P/E ratio
-38.83
Dividend yield
0.00%
52-week range
— – —
Volume
37.83K
Avg. volume
37.83K

Price performance · ROIVW

ROIVW price history

1M range · 0 trading sessions · Daily adjusted prices

ROIVW does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ROIVW news

The latest Smart Investors Daily articles mentioning ROIVW.

Stock researchCompany · Overview

ROIVW research

Overview

Company profile and research snapshot.

Company profile

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Aug 21, 2023

Presidential Hopeful Ramaswamy Predicts US Recession In 2024

In a recent interview with Tucker Carlson on X, presidential hopeful Vivek Ramaswamy spotlighted concerns about an impending U.S. recession in 2024, leaning heavily on historical indicators. What Happened: Central to his argument was the inverted yield curve, where interest rates on short-term bonds eclipse those on their long-term counterparts. Most investors know that the U.S. Treasury yield curve is considered a potent barometer for the U.S. business cycle. An upward-sloping curve — where longer-term rates exceed shorter-term ones — generally precedes economic expansion. The rarer inversion signals possible recessions, historically within 10 to 13 months. With the last inversion recorded in October 2022, Ramaswamy's ...Full story available on Benzinga.com

GlobeNewswire Inc. · Aug 2, 2023

Roivant Announces Redemption of Outstanding Warrants

BASEL, Switzerland and LONDON and NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will redeem all of its outstanding public warrants (the “Public Warrants”) and private placement warrants (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”) to purchase Roivant’s common shares (the “Common Shares”) pursuant to its Warrant Agreement dated September 30, 2021 with Equiniti Trust Company, LLC (formerly American Stock Transfer & Trust Company, LLC) as successor warrant agent (the “Warrant Agent”) (the “Warrant Agreement”), that remain outstanding following 5:00 p.m. New York City Time on September 1, 2023 (the “Redemption Date”) for a redemption price of $0.10 per Warrant (the “Redemption Price”).

Benzinga · Jun 28, 2023

Stocks Hold Steady, US Mulls China Chip Restrictions, Powell Sounds Hawkish: What's Driving Markets Wednesday

Stocks were mixed on Wednesday, with technology holding up better than the premarket predicted, despite a Wall Street Journal report that the U.S. government is considering semiconductor export limits to China. Fed Chair Jerome Powell stated at the ECB Forum on Central Banking that additional interest rate hikes – at least two – are on the way this year, without ruling out hiking at consecutive meetings. Furthermore, the Fed chair said the U.S. economy is highly resilient, and that a recession, while possible, is not the most likely scenario. The Fed is due to release the results of its annual stress tests for banks at 4:30 p.m. EDT Wednesday. Highlights from Wednesday’s Trading: The S&P 500 was slightly up (0.1%) as of midday trading, while the Dow slipped 0.2%. The tech-heavy Nasdaq 100 posted a 0.6% uptick, while small caps in the Russell 2000 gained 0.3% U.S. Indices’ Performance on Tuesday Index Performance (+/-) Value Nasdaq 100 +0.55% 15,020.54 S&P 500 Index +0.06% 4380.98 Dow Industrials -0.23% 33,849.65 Russell 2000 +0.27% 1,855.65 Analyst Color: An analyst is optimistic about the near-term market outlook, as he fell back on history to highlight the positivity. When the S&P 500 is up more than 10% for the year-to-date period at the end of June, the performance during the next six months is much better than the average, said Carson Group analyst Ryan Detrick. “But ...Full story available on Benzinga.com

GlobeNewswire Inc. · Jun 26, 2023

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provide Business Update on Wednesday, June 28, 2023

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, June 28, 2023, to report its financial results for the fourth quarter and fiscal year ended March 31, 2023, and provide business update.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By